<html>
<head>PUBMED IDs for APCL</head>
<body bgcolor='#C5F0F2'><h1>APCL</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9823329/'>Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin.</a> November 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10551328/'>Analysis of APCL, a brain-specific adenomatous polyposis coli homologue, for mutations and expression in brain tumors.</a> November 7  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11311560/'>Interaction of MCC2, a novel homologue of MCC tumor suppressor, with PDZ-domain Protein AIE-75.</a> April 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/15018807/'>Expression of Apc2 during mouse development.</a> March 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15590111/'>Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen.</a> December 14  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17211478/'>ASPP: a new family of oncogenes and tumour suppressor genes.</a> January 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/23840886/'>Functional comparison of human adenomatous polyposis coli (APC) and APC-like in targeting beta-catenin for degradation.</a> February 8  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24722208/'>different Roles for the axin interactions with the SAMP versus the second twenty amino acid repeat of adenomatous polyposis coli.</a> December 31  2014<br></body></html>
